Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 128 entries
Sorted by: Best Match Show Resources per page
Striving to obtain a school-work-life balance: The full-time doctoral student

student with dependents

Della MR.
GSID: bYHrMmFjdIsJ
E Martinez, C Ordu, MR Della Sala… - … Journal of Doctoral …, 2013 - informingscience.com

… the least recognized or acknowledged constraints on graduate students with dependents” (p. 36). However, participants with dependents in our study praised their faculty for their level …

Cite
Martinez, E., Ordu, C., Della Sala, M. R., & McFarlane, A. (2013). Striving to obtain a school-work-life balance: The full-time doctoral student. International Journal of Doctoral Studies, 8(39-59), 039-059.
Martinez, Edna, et al. "Striving to obtain a school-work-life balance: The full-time doctoral student." International Journal of Doctoral Studies 8.39-59 (2013): 039-059.
Copy Download .nbib Format: MLA
Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Frontiers in endocrinology

Lin B, Lin X, Stachel M, Wang E, Luo Y, Lader J, Sun X, Delmar M, Bu L.
PMID: 29067001
Front Endocrinol (Lausanne). 2017 Oct 09;8:253. doi: 10.3389/fendo.2017.00253. eCollection 2017.

With recent advances in stem cell technology, it is becoming efficient to differentiate human pluripotent stem cells (hPSCs) into cardiomyocytes, which can subsequently be used for myriad purposes, ranging from interrogating mechanisms of cardiovascular disease, developing novel cellular therapeutic...

Cite
Lin B, Lin X, Stachel M, et al. Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes. Front Endocrinol (Lausanne). 2017;8:253doi: 10.3389/fendo.2017.00253.
Lin, B., Lin, X., Stachel, M., Wang, E., Luo, Y., Lader, J., Sun, X., Delmar, M., & Bu, L. (2017). Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes. Frontiers in endocrinology, 8253. https://doi.org/10.3389/fendo.2017.00253
Lin, Bin, et al. "Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes." Frontiers in endocrinology vol. 8 (2017): 253. doi: https://doi.org/10.3389/fendo.2017.00253
Lin B, Lin X, Stachel M, Wang E, Luo Y, Lader J, Sun X, Delmar M, Bu L. Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes. Front Endocrinol (Lausanne). 2017 Oct 09;8:253. doi: 10.3389/fendo.2017.00253. eCollection 2017. PMID: 29067001; PMCID: PMC5641374.
Copy Download .nbib Format: NLM
Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus.

Frontiers in physiology

Sobrevia L, Salsoso R, Fuenzalida B, Barros E, Toledo L, Silva L, Pizarro C, Subiabre M, Villalobos R, Araos J, Toledo F, González M, Gutiérrez J, Farías M, Chiarello DI, Pardo F, Leiva A.
PMID: 27065887
Front Physiol. 2016 Mar 31;7:119. doi: 10.3389/fphys.2016.00119. eCollection 2016.

Gestational diabetes mellitus (GDM) is a disease of the mother that associates with altered fetoplacental vascular function. GDM-associated maternal hyperglycaemia result in fetal hyperglycaemia, a condition that leads to fetal hyperinsulinemia and altered L-arginine transport and synthesis of nitric...

Cite
Sobrevia L, Salsoso R, Fuenzalida B, et al. Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus. Front Physiol. 2016;7:119doi: 10.3389/fphys.2016.00119.
Sobrevia, L., Salsoso, R., Fuenzalida, B., Barros, E., Toledo, L., Silva, L., Pizarro, C., Subiabre, M., Villalobos, R., Araos, J., Toledo, F., González, M., Gutiérrez, J., Farías, M., Chiarello, D. I., Pardo, F., & Leiva, A. (2016). Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus. Frontiers in physiology, 7119. https://doi.org/10.3389/fphys.2016.00119
Sobrevia, Luis, et al. "Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus." Frontiers in physiology vol. 7 (2016): 119. doi: https://doi.org/10.3389/fphys.2016.00119
Sobrevia L, Salsoso R, Fuenzalida B, Barros E, Toledo L, Silva L, Pizarro C, Subiabre M, Villalobos R, Araos J, Toledo F, González M, Gutiérrez J, Farías M, Chiarello DI, Pardo F, Leiva A. Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus. Front Physiol. 2016 Mar 31;7:119. doi: 10.3389/fphys.2016.00119. eCollection 2016. PMID: 27065887; PMCID: PMC4815008.
Copy Download .nbib Format: NLM
Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma.

Cancer biotherapy & radiopharmaceuticals

DeLima M, Amato RJ, Jackson A, Tu SM, Banks M, Finn L, Ellerhorst J.
PMID: 10851489
Cancer Biother Radiopharm. 1997 Dec;12(6):365-70. doi: 10.1089/cbr.1997.12.365.

We have completed a phase I/II trial to evaluate the toxicity and efficacy of the combination of gamma interferon and 5-fluorouracil in metastatic renal cell carcinoma. Gamma interferon was administered at a weekly dose of 100 micrograms. 5-fluorouracil was...

Cite
DeLima M, Amato RJ, Jackson A, et al. Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer Biother Radiopharm. 1997;12(6):365-70doi: 10.1089/cbr.1997.12.365.
DeLima, M., Amato, R. J., Jackson, A., Tu, S. M., Banks, M., Finn, L., & Ellerhorst, J. (1997). Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer biotherapy & radiopharmaceuticals, 12(6), 365-70. https://doi.org/10.1089/cbr.1997.12.365
DeLima, et al. "Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma." Cancer biotherapy & radiopharmaceuticals vol. 12,6 (1997): 365-70. doi: https://doi.org/10.1089/cbr.1997.12.365
DeLima M, Amato RJ, Jackson A, Tu SM, Banks M, Finn L, Ellerhorst J. Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer Biother Radiopharm. 1997 Dec;12(6):365-70. doi: 10.1089/cbr.1997.12.365. PMID: 10851489.
Copy Download .nbib Format: NLM
Little or no solar wind enters Venus' atmosphere at solar minimum.

Nature

Zhang TL, Delva M, Baumjohann W, Auster HU, Carr C, Russell CT, Barabash S, Balikhin M, Kudela K, Berghofer G, Biernat HK, Lammer H, Lichtenegger H, Magnes W, Nakamura R, Schwingenschuh K, Volwerk M, Vörös Z, Zambelli W, Fornacon KH, Glassmeier KH, Richter I, Balogh A, Schwarzl H, Pope SA, Shi JK, Wang C, Motschmann U, Lebreton JP.
PMID: 18046399
Nature. 2007 Nov 29;450(7170):654-6. doi: 10.1038/nature06026.

Venus has no significant internal magnetic field, which allows the solar wind to interact directly with its atmosphere. A field is induced in this interaction, which partially shields the atmosphere, but we have no knowledge of how effective that...

Cite
Zhang TL, Delva M, Baumjohann W, et al. Little or no solar wind enters Venus' atmosphere at solar minimum. Nature. 2007;450(7170):654-6doi: 10.1038/nature06026.
Zhang, T. L., Delva, M., Baumjohann, W., Auster, H. U., Carr, C., Russell, C. T., Barabash, S., Balikhin, M., Kudela, K., Berghofer, G., Biernat, H. K., Lammer, H., Lichtenegger, H., Magnes, W., Nakamura, R., Schwingenschuh, K., Volwerk, M., Vörös, Z., Zambelli, W., Fornacon, K. H., Glassmeier, K. H., Richter, I., Balogh, A., Schwarzl, H., Pope, S. A., Shi, J. K., Wang, C., Motschmann, U., & Lebreton, J. P. (2007). Little or no solar wind enters Venus' atmosphere at solar minimum. Nature, 450(7170), 654-6. https://doi.org/10.1038/nature06026
Zhang, T L, et al. "Little or no solar wind enters Venus' atmosphere at solar minimum." Nature vol. 450,7170 (2007): 654-6. doi: https://doi.org/10.1038/nature06026
Zhang TL, Delva M, Baumjohann W, Auster HU, Carr C, Russell CT, Barabash S, Balikhin M, Kudela K, Berghofer G, Biernat HK, Lammer H, Lichtenegger H, Magnes W, Nakamura R, Schwingenschuh K, Volwerk M, Vörös Z, Zambelli W, Fornacon KH, Glassmeier KH, Richter I, Balogh A, Schwarzl H, Pope SA, Shi JK, Wang C, Motschmann U, Lebreton JP. Little or no solar wind enters Venus' atmosphere at solar minimum. Nature. 2007 Nov 29;450(7170):654-6. doi: 10.1038/nature06026. PMID: 18046399.
Copy Download .nbib Format: NLM
Complete Genome Sequence of the New Urolithin-Producing Bacterium .

Genome announcements

Martinez-Blanch JF, Ramón D, Beltrán D, Romo-Vaquero M, García-Villalba R, Espín JC, Tomás-Barberán FA, Codoñer FM, Selma MV.
PMID: 29242216
Genome Announc. 2017 Dec 14;5(50). doi: 10.1128/genomeA.01120-17.

No abstract available.

Cite
Martinez-Blanch JF, Ramón D, Beltrán D, et al. Complete Genome Sequence of the New Urolithin-Producing Bacterium . Genome Announc. 2017;5(50)doi: 10.1128/genomeA.01120-17.
Martinez-Blanch, J. F., Ramón, D., Beltrán, D., Romo-Vaquero, M., García-Villalba, R., Espín, J. C., Tomás-Barberán, F. A., Codoñer, F. M., & Selma, M. V. (2017). Complete Genome Sequence of the New Urolithin-Producing Bacterium . Genome announcements, 5(50), . https://doi.org/10.1128/genomeA.01120-17
Martinez-Blanch, Juan F, et al. "Complete Genome Sequence of the New Urolithin-Producing Bacterium ." Genome announcements vol. 5,50 (2017). doi: https://doi.org/10.1128/genomeA.01120-17
Martinez-Blanch JF, Ramón D, Beltrán D, Romo-Vaquero M, García-Villalba R, Espín JC, Tomás-Barberán FA, Codoñer FM, Selma MV. Complete Genome Sequence of the New Urolithin-Producing Bacterium . Genome Announc. 2017 Dec 14;5(50). doi: 10.1128/genomeA.01120-17. PMID: 29242216; PMCID: PMC5730666.
Copy Download .nbib Format: NLM
Neonatal respiratory distress in Omdurman Maternity Hospital, Sudan.

Sudanese journal of paediatrics

Abdelrahman SM, Hamed SM, Nasr A.
PMID: 27493392
Sudan J Paediatr. 2014;14(1):65-70.

Neonatal respiratory distress (NRD) is a common neonatal problem, which is responsible for high morbidity and mortality. There are few published studies in developing countries addressing neonatal respiratory distress. There is no previously published study in Sudan on this...

Cite
Abdelrahman SM, Hamed SM, Nasr A. Neonatal respiratory distress in Omdurman Maternity Hospital, Sudan. Sudan J Paediatr. 2014;14(1):65-70
Abdelrahman, S. M., Hamed, S. M., & Nasr, A. (2014). Neonatal respiratory distress in Omdurman Maternity Hospital, Sudan. Sudanese journal of paediatrics, 14(1), 65-70.
Abdelrahman, Sirageldin Mk, et al. "Neonatal respiratory distress in Omdurman Maternity Hospital, Sudan." Sudanese journal of paediatrics vol. 14,1 (2014): 65-70.
Abdelrahman SM, Hamed SM, Nasr A. Neonatal respiratory distress in Omdurman Maternity Hospital, Sudan. Sudan J Paediatr. 2014;14(1):65-70. PMID: 27493392; PMCID: PMC4949919.
Copy Download .nbib Format: NLM
Auxiliary master equation approach within stochastic wave functions: Application to the interacting resonant level model.

Physical review. E

Sorantin ME, Fugger DM, Dorda A, von der Linden W, Arrigoni E.
PMID: 31108647
Phys Rev E. 2019 Apr;99(4):043303. doi: 10.1103/PhysRevE.99.043303.

We present further developments of the auxiliary master equation approach (AMEA), a numerical method to simulate many-body quantum systems in as well as out of equilibrium and apply it to the interacting resonant level model to benchmark the new...

Cite
Sorantin ME, Fugger DM, Dorda A, et al. Auxiliary master equation approach within stochastic wave functions: Application to the interacting resonant level model. Phys Rev E. 2019;99(4):043303doi: 10.1103/PhysRevE.99.043303.
Sorantin, M. E., Fugger, D. M., Dorda, A., von der Linden, W., & Arrigoni, E. (2019). Auxiliary master equation approach within stochastic wave functions: Application to the interacting resonant level model. Physical review. E, 99(4), 043303. https://doi.org/10.1103/PhysRevE.99.043303
Sorantin, Max E, et al. "Auxiliary master equation approach within stochastic wave functions: Application to the interacting resonant level model." Physical review. E vol. 99,4 (2019): 043303. doi: https://doi.org/10.1103/PhysRevE.99.043303
Sorantin ME, Fugger DM, Dorda A, von der Linden W, Arrigoni E. Auxiliary master equation approach within stochastic wave functions: Application to the interacting resonant level model. Phys Rev E. 2019 Apr;99(4):043303. doi: 10.1103/PhysRevE.99.043303. PMID: 31108647.
Copy Download .nbib Format: NLM
Columbia University Master of Public Health Core Curriculum: Implementation, Student Experience, and Learning Outcomes, 2013-2018.

Public health reports (Washington, D.C. : 1974)

Garbers S, March D, Kornfeld J, Baumgartner SR, Wiggin M, Westley LA, Ballesteros-Gonzalez D, Delva M, Fried LP.
PMID: 33673776
Public Health Rep. 2022 Jan-Feb;137(1):168-178. doi: 10.1177/0033354921999162. Epub 2021 Mar 05.

OBJECTIVES: Public health education must respond to 21st-century public health challenges in an ever-evolving landscape. We describe implementation and educational outcomes of the Columbia University Master of Public Health (MPH) Core (hereinafter, Core) curriculum since its inception.METHODS: This retrospective...

Cite
Garbers S, March D, Kornfeld J, et al. Columbia University Master of Public Health Core Curriculum: Implementation, Student Experience, and Learning Outcomes, 2013-2018. Public Health Rep. 2021;137(1):168-178doi: 10.1177/0033354921999162.
Garbers, S., March, D., Kornfeld, J., Baumgartner, S. R., Wiggin, M., Westley, L. A., Ballesteros-Gonzalez, D., Delva, M., & Fried, L. P. (2022). Columbia University Master of Public Health Core Curriculum: Implementation, Student Experience, and Learning Outcomes, 2013-2018. Public health reports (Washington, D.C. : 1974), 137(1), 168-178. https://doi.org/10.1177/0033354921999162
Garbers, Samantha, et al. "Columbia University Master of Public Health Core Curriculum: Implementation, Student Experience, and Learning Outcomes, 2013-2018." Public health reports (Washington, D.C. : 1974) vol. 137,1 (2022): 168-178. doi: https://doi.org/10.1177/0033354921999162
Garbers S, March D, Kornfeld J, Baumgartner SR, Wiggin M, Westley LA, Ballesteros-Gonzalez D, Delva M, Fried LP. Columbia University Master of Public Health Core Curriculum: Implementation, Student Experience, and Learning Outcomes, 2013-2018. Public Health Rep. 2022 Jan-Feb;137(1):168-178. doi: 10.1177/0033354921999162. Epub 2021 Mar 05. PMID: 33673776.
Copy Download .nbib Format: NLM
There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication.

Microorganisms

Cortés-Martín A, Iglesias-Aguirre CE, Meoro A, Selma MV, Espín JC.
PMID: 32183480
Microorganisms. 2020 Mar 15;8(3). doi: 10.3390/microorganisms8030416.

The gut microbiota (GM) has attracted attention as a new target to combat several diseases, including metabolic syndrome (MetS), a pathological condition with many factors (diabetes, obesity, dyslipidemia, hypertension, etc.) that increase cardiovascular disease (CVD) risk. However, the existence...

Cite
Cortés-Martín A, Iglesias-Aguirre CE, Meoro A, et al. There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication. Microorganisms. 2020;8(3)doi: 10.3390/microorganisms8030416.
Cortés-Martín, A., Iglesias-Aguirre, C. E., Meoro, A., Selma, M. V., & Espín, J. C. (2020). There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication. Microorganisms, 8(3), . https://doi.org/10.3390/microorganisms8030416
Cortés-Martín, Adrián, et al. "There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication." Microorganisms vol. 8,3 (2020). doi: https://doi.org/10.3390/microorganisms8030416
Cortés-Martín A, Iglesias-Aguirre CE, Meoro A, Selma MV, Espín JC. There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication. Microorganisms. 2020 Mar 15;8(3). doi: 10.3390/microorganisms8030416. PMID: 32183480; PMCID: PMC7143903.
Copy Download .nbib Format: NLM
Which impact for proton pump inhibitors in SARS-COV-2 pneumonia.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Mazzeo G, Aronne L, Mariniello DF, Allocca V, Palma MI, Cerqua FS, Iadevaia C, Costigliola A, Parrella R, Bianco A, Covid Group V.
PMID: 34664895
Monaldi Arch Chest Dis. 2021 Oct 19; doi: 10.4081/monaldi.2021.1803. Epub 2021 Oct 19.

Identification of risk factors for severe outcome of Sars-Cov-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appears to...

Cite
Mazzeo G, Aronne L, Mariniello DF, et al. Which impact for proton pump inhibitors in SARS-COV-2 pneumonia. Monaldi Arch Chest Dis. 2021;doi: 10.4081/monaldi.2021.1803.
Mazzeo, G., Aronne, L., Mariniello, D. F., Allocca, V., Palma, M. I., Cerqua, F. S., Iadevaia, C., Costigliola, A., Parrella, R., Bianco, A., & Covid Group, V. (2021). Which impact for proton pump inhibitors in SARS-COV-2 pneumonia. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, . https://doi.org/10.4081/monaldi.2021.1803
Mazzeo, Grazia, et al. "Which impact for proton pump inhibitors in SARS-COV-2 pneumonia." Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace vol. (2021). doi: https://doi.org/10.4081/monaldi.2021.1803
Mazzeo G, Aronne L, Mariniello DF, Allocca V, Palma MI, Cerqua FS, Iadevaia C, Costigliola A, Parrella R, Bianco A, Covid Group V. Which impact for proton pump inhibitors in SARS-COV-2 pneumonia. Monaldi Arch Chest Dis. 2021 Oct 19; doi: 10.4081/monaldi.2021.1803. Epub 2021 Oct 19. PMID: 34664895.
Copy Download .nbib Format: NLM
What 'Omics can tell us about antifungal adaptation.

FEMS yeast research

Ribeiro GF, Denes E, Heaney H, Childers DS.
PMID: 34958354
FEMS Yeast Res. 2022 Jan 11;21(8). doi: 10.1093/femsyr/foab070.

Invasive candidiasis, the most frequent healthcare-associated invasive fungal infection, is commonly caused by Candida albicans. However, in recent years other antifungal-resistant Candida species-namely Candida glabrata and Candidaauris-have emerged as a serious matter of concern. Much of our understanding of...

Cite
Ribeiro GF, Denes E, Heaney H, et al. What 'Omics can tell us about antifungal adaptation. FEMS Yeast Res. 2022;21(8)doi: 10.1093/femsyr/foab070.
Ribeiro, G. F., Denes, E., Heaney, H., & Childers, D. S. (2022). What 'Omics can tell us about antifungal adaptation. FEMS yeast research, 21(8), . https://doi.org/10.1093/femsyr/foab070
Ribeiro, Gabriela Fior, et al. "What 'Omics can tell us about antifungal adaptation." FEMS yeast research vol. 21,8 (2022). doi: https://doi.org/10.1093/femsyr/foab070
Ribeiro GF, Denes E, Heaney H, Childers DS. What 'Omics can tell us about antifungal adaptation. FEMS Yeast Res. 2022 Jan 11;21(8). doi: 10.1093/femsyr/foab070. PMID: 34958354; PMCID: PMC8755904.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 128 entries